| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 9496 |
| 1 | PEGFILGRASTIM | 1575 |
| 2 | CARFILZOMIB | 367 |
| 3 | BLINATUMOMAB | 111 |
| 4 | BEVACIZUMAB-AWWB | 54 |
| 5 | ROMIPLOSTIM | 49 |
| 6 | TRASTUZUMAB-ANNS | 42 |
| 7 | AFLIBERCEPT | 39 |
| 8 | BICALUTAMIDE | 31 |
| 9 | DENOSUMAB | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM | 1575 | 0.1315 |
| 1 | LEUPROLIDE ACETATE | 9496 | 0.1215 |
| 2 | AVACINCAPTAD PEGOL | 25 | 0.0710 |
| 3 | TRASTUZUMAB-ANNS | 42 | 0.0277 |
| 4 | IMETELSTAT SODIUM | 5 | 0.0269 |
| 5 | AFLIBERCEPT-AYYH | 2 | 0.0198 |
| 6 | CARFILZOMIB | 367 | 0.0129 |
| 7 | BEVACIZUMAB-AWWB | 54 | 0.0115 |
| 8 | BLINATUMOMAB | 111 | 0.0104 |
| 9 | POLYETHYLENE GLYCOL, UNSPECIFIED | 1 | 0.0100 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 16 | 0.0233 |
| 1 | Leukocyte Growth Factor [EPC] | 1580 | 0.0111 |
| 2 | Endoglycosidase [EPC] | 8 | 0.0043 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 49 | 0.0032 |
| 4 | Proteasome Inhibitor [EPC] | 367 | 0.0032 |
| 5 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 6 | Selective T Cell Costimulation Blocker [EPC] | 14 | 0.0030 |
| 7 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 11 | 0.0027 |
| 8 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 4 | 0.0026 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 14 | 0.0024 |